|
Cerezo-Manchado JJ, Rosafalco M, Antón AI, Pérez-Andreu V, Garcia-Barberá N, Martinez AB, Corral J, Vicente V, González-Conejero R, Roldán V. Creating a genotype-based dosing algorithm for acenocoumarol steady dose. Thromb Haemost. 2013 Jan;109(1):146-53. doi: 10.1160/TH12-08-0631. PubMed PMID: 23196355.
AÑO: 2013; IF: 5.76
|
23196355
|
Pérez-Andreu V, Teruel R, Corral J, Roldán V, García-Barberá N, Salloum-Asfar S, Gómez-Lechón MJ, Bourgeois S, Deloukas P, Wadelius M, Vicente V, González-Conejero R, Martínez C. miR-133a regulates vitamin K 2,3-epoxide reductase complex subunit 1 (VKORC1), a key protein in the vitamin K cycle. Mol Med. 2013 Jan 22;18:1466-72. doi: 10.2119/molmed.2012.00062. PubMed PMID: 23154637; PubMed Central PMCID: PMC3563709.
AÑO: 2012; IF: 4.469
|
|
Roldán Schilling V, Vicente García V. [Pharmacodynamic and pharmacokinetic characteristics. Mechanism of action of the new oral anticoagulants]. Med Clin (Barc). 2012 Oct;139 Suppl 2:10-2. doi: 10.1016/S0025-7753(12)70035-0. Review. Spanish. PubMed PMID: 23498066.
AÑO: 2012; IF: 1.399
|
|
Jover E, Marín F, Roldán V, Montoro-García S, Valdés M, Lip GY. Atherosclerosis and thromboembolic risk in atrial fibrillation: focus on peripheral vascular disease. Ann Med. 2013 May;45(3):274-90. doi: 10.3109/07853890.2012.732702. Review. PubMed PMID: 23216106.
AÑO: 2013; IF: 4.733
|
|
Vílchez JA, Roldán V, Hernández-Romero D, Valdés M, Lip GY, Marín F. Biomarkers in atrial fibrillation: an overview. Int J Clin Pract. 2014 Apr;68(4):434-43. doi: 10.1111/ijcp.12304. Review. PubMed PMID: 24372915.
AÑO: 2014; IF: 2.566
|